JP2014104239A - Intraocular lens - Google Patents
Intraocular lens Download PDFInfo
- Publication number
- JP2014104239A JP2014104239A JP2012260647A JP2012260647A JP2014104239A JP 2014104239 A JP2014104239 A JP 2014104239A JP 2012260647 A JP2012260647 A JP 2012260647A JP 2012260647 A JP2012260647 A JP 2012260647A JP 2014104239 A JP2014104239 A JP 2014104239A
- Authority
- JP
- Japan
- Prior art keywords
- intraocular lens
- optical
- optical part
- acrylamide
- support part
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003287 optical effect Effects 0.000 claims abstract description 76
- 239000000178 monomer Substances 0.000 claims abstract description 41
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 25
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 22
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 19
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 13
- 239000011347 resin Substances 0.000 claims abstract description 13
- 229920005989 resin Polymers 0.000 claims abstract description 13
- 239000004925 Acrylic resin Substances 0.000 claims abstract description 5
- 229920000178 Acrylic resin Polymers 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 17
- WFKDPJRCBCBQNT-UHFFFAOYSA-N n,2-dimethylprop-2-enamide Chemical group CNC(=O)C(C)=C WFKDPJRCBCBQNT-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 30
- 238000007334 copolymerization reaction Methods 0.000 abstract description 4
- 210000000695 crystalline len Anatomy 0.000 description 53
- 239000000499 gel Substances 0.000 description 28
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 6
- 238000005304 joining Methods 0.000 description 6
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 6
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 4
- 239000012965 benzophenone Substances 0.000 description 4
- 239000007767 bonding agent Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 229910001873 dinitrogen Inorganic materials 0.000 description 4
- 239000011261 inert gas Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000003505 polymerization initiator Substances 0.000 description 4
- 238000005452 bending Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 2
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 210000003190 lens capsule crystalline Anatomy 0.000 description 2
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 2
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 2
- 239000002114 nanocomposite Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000009864 tensile test Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 1
- IEVADDDOVGMCSI-UHFFFAOYSA-N 2-hydroxybutyl 2-methylprop-2-enoate Chemical compound CCC(O)COC(=O)C(C)=C IEVADDDOVGMCSI-UHFFFAOYSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- SBVKVAIECGDBTC-UHFFFAOYSA-N 4-hydroxy-2-methylidenebutanamide Chemical compound NC(=O)C(=C)CCO SBVKVAIECGDBTC-UHFFFAOYSA-N 0.000 description 1
- NQSLZEHVGKWKAY-UHFFFAOYSA-N 6-methylheptyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C(C)=C NQSLZEHVGKWKAY-UHFFFAOYSA-N 0.000 description 1
- DXPPIEDUBFUSEZ-UHFFFAOYSA-N 6-methylheptyl prop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C=C DXPPIEDUBFUSEZ-UHFFFAOYSA-N 0.000 description 1
- COCLLEMEIJQBAG-UHFFFAOYSA-N 8-methylnonyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)=C COCLLEMEIJQBAG-UHFFFAOYSA-N 0.000 description 1
- LVGFPWDANALGOY-UHFFFAOYSA-N 8-methylnonyl prop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C=C LVGFPWDANALGOY-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- NQSMEZJWJJVYOI-UHFFFAOYSA-N Methyl 2-benzoylbenzoate Chemical compound COC(=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 NQSMEZJWJJVYOI-UHFFFAOYSA-N 0.000 description 1
- CNCOEDDPFOAUMB-UHFFFAOYSA-N N-Methylolacrylamide Chemical compound OCNC(=O)C=C CNCOEDDPFOAUMB-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 229940024874 benzophenone Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004154 testing of material Methods 0.000 description 1
- KEROTHRUZYBWCY-UHFFFAOYSA-N tridecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCOC(=O)C(C)=C KEROTHRUZYBWCY-UHFFFAOYSA-N 0.000 description 1
- XOALFFJGWSCQEO-UHFFFAOYSA-N tridecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCOC(=O)C=C XOALFFJGWSCQEO-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
本発明は透明で高屈折率なゲル材料を用いた軟性の眼内レンズに関する。 The present invention relates to a soft intraocular lens using a transparent and high refractive index gel material.
従来、水晶体を取り除いた後に眼内に設置される眼内レンズが知られている。眼内レンズは所定の屈折力を有する光学部と、この光学部を眼内にて支持する支持部とから構成されており、白内障となった混濁した水晶体を超音波乳化吸引術により水晶体嚢から取り除いた後に、眼内レンズを水晶体嚢内にて固定支持させることによって水晶体の代替をさせるようにしている。また、近年では、眼内において調節力を持たせた眼内レンズの検討がされている。このように調節力を持たせた眼内レンズとしては、2枚の光学部とその光学部の間にゲル状の弾性部材を接合させ、毛様筋の緊張・弛緩に応じて両光学部の軸間距離を変化させることにより調節力を得るものが知られている(特許文献1参照)。 Conventionally, an intraocular lens that is installed in the eye after removing the crystalline lens is known. The intraocular lens is composed of an optical part having a predetermined refractive power and a support part that supports the optical part in the eye, and the turbid lens that has become a cataract is removed from the lens capsule by ultrasonic emulsification aspiration. After removal, the lens is replaced by fixing and supporting the intraocular lens in the lens capsule. In recent years, an intraocular lens having an intraocular accommodation has been studied. As an intraocular lens having such an adjustment force, a gel-like elastic member is bonded between two optical parts and the optical part, and both optical parts are adjusted according to the tension and relaxation of the ciliary muscle. One that obtains an adjustment force by changing the distance between the axes is known (see Patent Document 1).
このように2枚の光学部の軸間距離を変化させるために用いられるゲル状の弾性部材は、レンズの軸方向への動きが可能なように軟性を有するとともに、ある程度の弾力性を確保する必要がある。また一方で、このような眼内レンズを小さく折り畳んで眼内に挿入するためには、折り畳み時における変形に耐えうる強度が必要となる。さらに、このようなゲル状の弾性部材をレンズ間の接合部材として用いるだけではなく、レンズを嚢内で固定保持させるための支持部の役目や光学部の素材として利用するためには、強度、透明性、屈折率等の種々の要素を考慮しなければならない。 The gel-like elastic member used to change the distance between the axes of the two optical parts in this way has flexibility so that the lens can move in the axial direction, and ensures a certain degree of elasticity. There is a need. On the other hand, in order to fold such an intraocular lens into a small size and insert it into the eye, it is necessary to have strength that can withstand deformation during folding. Furthermore, in addition to using such a gel-like elastic member as a joining member between lenses, in order to use the role of a support part for fixing and holding a lens in a sac or as a material of an optical part, strength, transparency Various factors such as property and refractive index must be considered.
上記従来技術の問題点に鑑み、本発明は透明性が良く、強度に優れたゲル状の素材を用いた眼内レンズを提供することを技術課題とする。 In view of the above-described problems of the prior art, an object of the present invention is to provide an intraocular lens using a gel material having good transparency and excellent strength.
上記課題を解決するために、本発明は以下のような構成を備えることを特徴とする。
(1) 所定の屈折力を有する光学部と、該光学部を眼内にて保持するための支持部とを有する眼内レンズにおいて、前記光学部はアクリル系樹脂またはアクリルアミド系樹脂からなり、前記支持部はアクリルアミド系樹脂からなることを特徴とする。
(2) 前記支持部に用いられる前記アクリルアミド系樹脂は、アクリルアミド系親水性モノマー及びアクリル系疎水性モノマーとを架橋剤の存在下にて共重合することによって形成されていることを特徴とする。
(3) 前記光学部に用いられる樹脂はアクリルアミド系樹脂であり、該アクリル系樹脂はアクリルアミド系親水性モノマー及びアクリル系疎水性モノマーとを架橋剤の存在下にて共重合することによって形成されていることを特徴とする。
(4) 前記光学部及び支持部の組成物として用いられる前記アクリルアミド系親水性モノマーはN,N´-ジメチルアクリルアミドであることを特徴とする。
(5) 前記光学部及び支持部の組成物として用いられる前記アクリル系疎水性モノマーは炭素数12〜18のアルキル基またはその誘導体を側鎖に含むアクリレートであることを特徴とする。
In order to solve the above problems, the present invention is characterized by having the following configuration.
(1) In an intraocular lens having an optical part having a predetermined refractive power and a support part for holding the optical part in the eye, the optical part is made of an acrylic resin or an acrylamide resin, The support portion is made of an acrylamide resin.
(2) The acrylamide resin used for the support is formed by copolymerizing an acrylamide hydrophilic monomer and an acrylic hydrophobic monomer in the presence of a crosslinking agent.
(3) The resin used in the optical part is an acrylamide resin, and the acrylic resin is formed by copolymerizing an acrylamide hydrophilic monomer and an acrylic hydrophobic monomer in the presence of a crosslinking agent. It is characterized by being.
(4) The acrylamide-based hydrophilic monomer used as the composition of the optical part and the support part is N, N′-dimethylacrylamide.
(5) The acrylic hydrophobic monomer used as the composition of the optical part and the support part is an acrylate containing an alkyl group having 12 to 18 carbon atoms or a derivative thereof in the side chain.
本発明によれば、透明性が良く、強度に優れたゲル状の素材を用いた眼内レンズを得ることができる。 According to the present invention, it is possible to obtain an intraocular lens using a gel material having good transparency and excellent strength.
本発明の実施形態を説明する。図1は本実施形態の眼内レンズの一例を示した模式図であり、図2は図1に示す眼内レンズの断面を示す模式図である。本実施形態の眼内レンズ1は所定の屈折力を持つ光学部2と、光学部2を嚢内等の眼内で固定保持するための支持部3とからなる。なお、本実施形態において、光学部は所定の屈折力を持つ2枚の光学部(第1光学部2a、第2光学部2b)からなり、支持部3は両光学部2a,2bを接合するとともに眼内で光学部を保持するための役割を果たす。なお、支持部3は接合された両光学部の軸間距離を変化させるための弾性部材としての役割としての役割も果たす。 An embodiment of the present invention will be described. FIG. 1 is a schematic diagram showing an example of an intraocular lens of the present embodiment, and FIG. 2 is a schematic diagram showing a cross section of the intraocular lens shown in FIG. The intraocular lens 1 of the present embodiment includes an optical unit 2 having a predetermined refractive power and a support unit 3 for fixing and holding the optical unit 2 in the eye such as a sac. In the present embodiment, the optical unit is composed of two optical units (first optical unit 2a and second optical unit 2b) having a predetermined refractive power, and the support unit 3 joins both optical units 2a and 2b. At the same time, it plays the role of holding the optical part in the eye. In addition, the support part 3 also serves as a role as an elastic member for changing the distance between the axes of the joined optical parts.
本実施形態の光学部2(2a,2b)及び支持部3は透明形状記憶ゲルからなる光学部2及び支持部2に用いられる透明形状記憶ゲルは、アクリルアミド系親水性モノマー及びアクリル系疎水性モノマーを架橋剤の存在下において共重合することによって得られる。 The optical part 2 (2a, 2b) and the support part 3 of the present embodiment are made of a transparent shape memory gel, and the transparent shape memory gel used for the support part 2 is an acrylamide hydrophilic monomer and an acrylic hydrophobic monomer. Can be obtained by copolymerization in the presence of a crosslinking agent.
透明形状記憶ゲルの組成物として用いられるアクリルアミド系親水性モノマーとしては、具体的にはN,N-ジメチルアクリルアミド、アクリルアミド,イソプロピルアクリルアミド,N-(ヒドロキシメチル)アクリルアミド,ヒドロキシエチルアクリルアミド,アクリル酸,アクリル酸ナトリウム等を用いることができる。特にN,N-ジメチルアクリルアミドは、常温で液体のため、無溶媒での共重合が可能になり、溶媒が反応を阻害することがなく均一に反応が進むので透明度が高くなる。また、溶媒を使用しないと最大応力、最大ひずみの両方を大きくすることができる。 Specific examples of acrylamide-based hydrophilic monomers used in the composition of transparent shape memory gel include N, N-dimethylacrylamide, acrylamide, isopropylacrylamide, N- (hydroxymethyl) acrylamide, hydroxyethylacrylamide, acrylic acid, acrylic Sodium acid or the like can be used. In particular, since N, N-dimethylacrylamide is liquid at room temperature, it can be copolymerized without a solvent, and the reaction proceeds uniformly without inhibiting the reaction of the solvent. Moreover, if a solvent is not used, both the maximum stress and the maximum strain can be increased.
透明形状記憶ゲルの組成物として用いられるアクリル系疎水性モノマーとしては、例えば疎水性基として炭素数8〜18のアルキル基またはその誘導体を側鎖に含むアクリレート、メタクリレート等を用いることができる。具体的には、ステアリルアクリレート、ラウリルアクリレート、イソデシルアクリレート、イソオクチルアクリレート、トリデシルアクリレート、ステアリルメタクリレート、ラウリルアクリレート、イソデシルメタクリレート、イソオクチルメタクリレート、トリデシルメタクリレート,メタクリル酸メチル等を挙げることができ、特にラウリルアクリレート、ステアリルアクリレートを好適に用いることができる。また、アクリル系疎水性モノマーとして芳香族や不飽和を含んでいても結晶性がある様な化学構造であれば用いることが可能である。 As the acrylic hydrophobic monomer used as the composition of the transparent shape memory gel, for example, an acrylate or methacrylate having a side chain of an alkyl group having 8 to 18 carbon atoms or a derivative thereof as a hydrophobic group can be used. Specific examples include stearyl acrylate, lauryl acrylate, isodecyl acrylate, isooctyl acrylate, tridecyl acrylate, stearyl methacrylate, lauryl acrylate, isodecyl methacrylate, isooctyl methacrylate, tridecyl methacrylate, and methyl methacrylate. In particular, lauryl acrylate and stearyl acrylate can be preferably used. Moreover, it is possible to use any chemical structure that has crystallinity even if it contains aromatic or unsaturated as an acrylic hydrophobic monomer.
架橋剤としては、例えば、エチレングリコールジメタクリレート,ポリエチレングリコールジメタクリレート,ジエチレングリコールジメタクリレート,トリエチレングリコールジメタクリレート等のジメタクリル酸エステルや、N,N´-メチレンビスアクリルアミド、ジビニルベンゼン等、その他眼内レンズ基材の作成に架橋剤として使用可能な材料が挙げられる。 Examples of the crosslinking agent include dimethacrylic acid esters such as ethylene glycol dimethacrylate, polyethylene glycol dimethacrylate, diethylene glycol dimethacrylate, and triethylene glycol dimethacrylate, N, N′-methylenebisacrylamide, divinylbenzene, and other intraocular. The material which can be used as a crosslinking agent for preparation of a lens base material is mentioned.
また,近年開発された環動ゲル,ナノコンポジットゲル,ダブルネットワークゲル,相互架橋網目ゲル等にみられる機械特性に優れたゲルを作成するために利用される各種の架橋網目構造を用いることができる。すなわち,環動ゲルではシクロデキストリン等を用いた環状分子による動く架橋構造,ナノコンポジットゲルではクレイ粒子による多官能末端架橋構造,ダブルネットワークゲルでは2種類の高分子による相互浸透網目構造,相互架橋網目ゲルでは2種類以上の高分子が互いに異なる種類の高分子の間だけで架橋する網目構造等である。 In addition, various cross-linked network structures used to create gels with excellent mechanical properties, such as those developed in recently developed ring gels, nanocomposite gels, double network gels, and cross-crosslinked network gels, can be used. . In other words, a cyclic cross-linking structure with cyclic molecules using cyclodextrin, etc. for cyclizing gels, a polyfunctional end-crosslinking structure with clay particles for nanocomposite gels, an interpenetrating network structure with two types of polymers for double network gels, and an intercrosslinking network. A gel has a network structure in which two or more kinds of polymers are crosslinked only between different kinds of polymers.
これらのモノマーを原料として、無溶媒またはエタノールなどの溶媒存在下に共重合を行う。アクリルアミド系親水性モノマー及びアクリル系疎水性モノマーの量比は、例えば、モル比で10:1〜1:1(アクリルアミド系親水性モノマー:アクリル系疎水性モノマー)の範囲内とすることができる。透明度を高くするには、アクリル系疎水性モノマーの比率を低くするほうが良く、10:1〜3:1程度が良い。 Using these monomers as raw materials, copolymerization is carried out in the absence of a solvent or in the presence of a solvent such as ethanol. The amount ratio of the acrylamide hydrophilic monomer and the acrylic hydrophobic monomer can be, for example, in a molar ratio of 10: 1 to 1: 1 (acrylamide hydrophilic monomer: acrylic hydrophobic monomer). In order to increase the transparency, it is better to decrease the ratio of the acrylic hydrophobic monomer, and it is preferably about 10: 1 to 3: 1.
架橋剤の量は、例えばモノマー全量(本実施形態ではアクリルアミド系親水性モノマーとアクリル系疎水性モノマーを合わせた量)に対して、0.005〜5mol%の範囲内とすることができる。重合法は特に限定されるものではないが、例えば、ラジカル重合により合成することができる。反応開始剤(重合開始剤)としては、光重合開始剤が好ましく、例えばベンゾフェノン、α-ケトグルタル酸、ベンゾイン,メチルオルトベンゾイルベンゾエート,アセトフェノン等の眼内レンズ基材の形成に重合開始剤として使用可能な材料が挙げられる。 The amount of the crosslinking agent can be, for example, in the range of 0.005 to 5 mol% with respect to the total amount of monomers (in this embodiment, the total amount of acrylamide hydrophilic monomer and acrylic hydrophobic monomer). The polymerization method is not particularly limited, but can be synthesized by radical polymerization, for example. As the reaction initiator (polymerization initiator), a photopolymerization initiator is preferable. For example, it can be used as a polymerization initiator for forming intraocular lens base materials such as benzophenone, α-ketoglutaric acid, benzoin, methylorthobenzoylbenzoate, and acetophenone. Materials.
なお、光学部、及び支持部ともに上述した材料を用いて形成することができるが、光学部に対して支持部をより硬く、強度を向上させたい場合には、透明形状記憶ゲルの組成物として用いられるアクリルアミド系親水性モノマーを主材料とし、副材料としては光学部に用いられるアクリル系疎水性モノマーよりもガラス転移温度が高いアクリル系疎水性モノマーを採用することにより、より硬く、強度が向上した透明形状記憶ゲルを得ることができる。 In addition, although both the optical part and the support part can be formed using the above-mentioned materials, the support part is harder than the optical part, and when it is desired to improve the strength, the composition of the transparent shape memory gel is used. The main material is the acrylamide hydrophilic monomer used, and the secondary material is an acrylic hydrophobic monomer that has a glass transition temperature higher than that of the acrylic hydrophobic monomer used in the optical part. A transparent shape memory gel can be obtained.
また、第1光学部2a及び第2光学部2bの曲率は、眼内レンズ1全体として所望する屈折力が得られるように各々決定されている。なお、本実施形態の眼内レンズ1では、図2に示するように、患者眼の水晶体嚢に眼内レンズ1を入れた際の前側(前眼部側)が凸レンズ(正のレンズ)である第1光学部材2a、後側が凹レンズ(負のレンズ)である第2光学部材2aとしているが、これに限るものではない。凸レンズ、凹レンズ、メニスカスレンズ等の各種形状のレンズの組合せにより、眼内レンズ1の調節機能が好適に作用する組合せを選択すればよい。また、第1光学部2a及び第2光学部2bは、図示すように支持部3に各々接合されるため、各光学部の接合箇所(第1光学部2a後面及び第2光学部2b前面の接合箇所)は平面であることが好ましい。また、支持部の形状は図1に示すものに限るものではなく、素材による弾性力に加えて、その形状に基づいた弾性力が得られるようにすることもできる。例えば図3に示すように横切断面形状が略弓状となる支持部4を用いることもできる。 Further, the curvatures of the first optical unit 2a and the second optical unit 2b are respectively determined so that a desired refractive power can be obtained for the entire intraocular lens 1. In the intraocular lens 1 of the present embodiment, as shown in FIG. 2, the front side (anterior eye side) when the intraocular lens 1 is inserted into the crystalline lens capsule of the patient's eye is a convex lens (positive lens). Although a certain first optical member 2a and a second optical member 2a having a concave lens (negative lens) on the rear side are used, the present invention is not limited to this. What is necessary is just to select the combination with which the adjustment function of the intraocular lens 1 acts suitably with the combination of lenses of various shapes, such as a convex lens, a concave lens, a meniscus lens. Further, since the first optical part 2a and the second optical part 2b are respectively joined to the support part 3 as shown in the figure, the joining positions of the optical parts (the rear surface of the first optical part 2a and the front surface of the second optical part 2b). The joining portion is preferably a flat surface. Further, the shape of the support portion is not limited to that shown in FIG. 1, and an elastic force based on the shape can be obtained in addition to the elastic force due to the material. For example, as shown in FIG. 3, a support portion 4 having a substantially arcuate cross-sectional shape can be used.
また、第1光学部2aと第2光学部2bとを支持部3にて接合させるための接合剤は、眼内レンズ1を水晶体嚢に設置後、光学部2や支持部3が膨潤することにより光学部材の剥がれ、軸ズレが生じず、さらに眼内レンズ挿入時において、眼内レンズ(光学部、支持部)の折り畳みによって剥がれない程度の接合力を有するものであればよい。このような、接合剤は生体適合性が良く、眼内レンズ基材の材料を侵さない既知の接着剤を用いることができる。また、光学部2及び支持部3に用いた材料のモノマーを複数混合し、これを接合剤として用い、光学部及び支持部と接合剤とを共重合によって接合させることもできる。 In addition, the bonding agent for bonding the first optical unit 2a and the second optical unit 2b with the support unit 3 causes the optical unit 2 and the support unit 3 to swell after the intraocular lens 1 is placed on the crystalline lens capsule. As long as the optical member is peeled off and no axial displacement occurs, and the intraocular lens is inserted, the optical member only needs to have a bonding force that does not peel off due to the folding of the intraocular lens (optical part, support part). Such a bonding agent has good biocompatibility, and a known adhesive that does not attack the material of the intraocular lens base material can be used. Moreover, the monomer of the material used for the optical part 2 and the support part 3 can be mixed, and this can be used as a bonding agent, and an optical part, a support part, and a bonding agent can also be joined by copolymerization.
なお、第1光学部2a及び第2光学部2bと支持部3とを接合させる場合には、両光学部の光軸を一致させた状態で接合させる。また、接合の際には、図1に示すように第1光学部2aと第2光学部との間に形成される内部空間に眼内の体液が侵入することができる程度に光学部間に隙間を持たせて接合させておくことが好ましい。 In addition, when joining the 1st optical part 2a and the 2nd optical part 2b, and the support part 3, it joins in the state which made the optical axis of both optical parts correspond. In addition, when joining, as shown in FIG. 1, the intraocular body fluid can penetrate into the internal space formed between the first optical unit 2a and the second optical unit. It is preferable to join them with a gap.
また、このような光学部(第1光学部2及び第2光学部2a)の形成は、例えば型内に眼内レンズ基材となるモノマーの混合液を流し込んでおき、重合硬化させることによって、所望する形状を得てもよいし、モノマーの混合液を板状や棒状に重合硬化させた後、切削加工によって所望する形状を得ることもできる。支持部3の形成においても同様である。なお、光学部、及び支持部の形状は、完全に含水された状態(使用される状態)で所望する形状となるように考慮しなければならない。また,モノマー溶液に光を照射する事で,立体的に重合物を得ることも可能である。 Moreover, the formation of such an optical part (the first optical part 2 and the second optical part 2a), for example, by pouring a mixture of monomers to be an intraocular lens base material into a mold and curing it by polymerization, A desired shape may be obtained, or a desired shape may be obtained by cutting after a monomer liquid mixture is polymerized and cured into a plate shape or a rod shape. The same applies to the formation of the support portion 3. In addition, the shape of the optical part and the support part must be considered so as to have a desired shape in a completely water-containing state (used state). It is also possible to obtain a polymer in a three-dimensional manner by irradiating the monomer solution with light.
また、本実施形態では眼内レンズとして2枚の光学部を用いる例を示したが、これに限るものではない。例えば、従来の眼内レンズのように1枚の光学部にループ状、或いはプレート状の支持部を設けた1ピースタイプ,3ピースタイプ,Refillingタイプの眼内レンズに本実施形態の透明形状記憶ゲルを用いても良い。また、光学部は眼内レンズの基材として用いられている疎水性,或いは親水性の軟性アクリル基材,シリコーン樹脂やハイドロゲルとし、本発明の透明形状記憶ゲルは支持部(2つ以上の光学部を接合・支持するための支持部を含む)のみに用いることもできる。なお、支持部にこのようなゲルを用いる場合には、透明である必要はない。 In the present embodiment, an example in which two optical units are used as intraocular lenses is shown, but the present invention is not limited to this. For example, the transparent shape memory of this embodiment is used for a one-piece type, a three-piece type, or a refilling type intraocular lens in which a loop-like or plate-like support part is provided on a single optical part like a conventional intraocular lens. A gel may be used. The optical part is a hydrophobic or hydrophilic soft acrylic base material used as a base material for an intraocular lens, a silicone resin or a hydrogel, and the transparent shape memory gel of the present invention has a support part (two or more It can also be used only for including a support part for joining and supporting the optical part. In addition, when using such a gel for a support part, it does not need to be transparent.
光学部に用いられる疎水性のアクリル材料としては、メチルアクリレート,エチルアクリレート,プロピルアクリレート,2−エチルヘキシルアクリレート,ブチルアクリレート,等のアクリル酸エステルモノマーや、メチルメタクリレート,エチルメタクリレート,プロピルメタクリレート,ブチルメタクリレート等のメタクリル酸エステルモノマーが挙げられる。また、親水性のアクリル材料としては、ヒドロキシエチルメタクリレート、2-ヒドロキシプロピルメタクリレート,2-ヒドロキシブチルメタクリレート等が挙げられる。これらの材料を1又は2以上組み合わせて重合させることにより、疎水性、或いは親水性の軟性アクリル基材を得ることができる。 Examples of hydrophobic acrylic materials used in the optical part include acrylic acid ester monomers such as methyl acrylate, ethyl acrylate, propyl acrylate, 2-ethylhexyl acrylate, and butyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate, and butyl methacrylate. Methacrylic acid ester monomers. Examples of the hydrophilic acrylic material include hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate, 2-hydroxybutyl methacrylate and the like. By polymerizing one or more of these materials in combination, a hydrophobic or hydrophilic soft acrylic substrate can be obtained.
以下に、本実施形態で用いられる透明形状記憶ゲルに関する実施例を挙げ、詳しく説明するが、本発明はこれらの実施例に何ら限定されるものではない。
<実施例1>
モノマーとして、N,N´-ジメチルアクリルアミドを0.75M、ステアリルアクリレート(SA)を0.25M、架橋剤としてN,N´-メチレンビスアクリルアミドを0.05Mol%、重合開始剤としてベンゾフェノンを0.1Mol%の割合で秤量し、混合した。この混合液を不活性ガス下(窒素ガス)のもとで15分間撹拌した。その後、予め作成した透明な型内に撹拌した混合液を流し込み、紫外線ランプを24時間照射させることにより、光学部と支持部とが形成された1ピースプレート型眼内レンズを模した形状の基材(ゲル)を得た。得られた基材に対して十分に含水させた状態で、透明性、折り曲げと復元の評価を行った。
折り曲げは、鑷子を用いて支持部を曲げて光学部に載せられた状態で、さらに光学部を折り畳むことができるかを評価した。さらに支持部が載せられた状態で折り畳まれた光学部を鑷子から解放し、光学部及び支持部ともに破損なく当初の状態まで復元することができるか否かを評価した。破損なく折り曲げ、復元ができれば○、破損の発生,折り曲げ不可,復元不可の何れかに該当していれば×とした。また、屈折率の測定、引張試験による評価も行った。屈折率の測定は屈折計(RA-600 京都電子工業社製)を用い、23℃,D線での測定を行った。引張試験は卓上型材料試験機(STA-1150 オリエンテック社製)を用いて,23℃にて測定した。その結果を表1に示す。
Hereinafter, examples relating to the transparent shape memory gel used in the present embodiment will be described in detail, but the present invention is not limited to these examples.
<Example 1>
N, N′-dimethylacrylamide as a monomer is 0.75 M, stearyl acrylate (SA) is 0.25 M, N, N′-methylenebisacrylamide is 0.05 mol% as a cross-linking agent, and benzophenone is 0. Weighed and mixed at a ratio of 1 mol%. The mixture was stirred for 15 minutes under inert gas (nitrogen gas). After that, the mixed liquid stirred is poured into a transparent mold prepared in advance, and irradiated with an ultraviolet lamp for 24 hours, so that the base having a shape imitating a one-piece plate type intraocular lens in which an optical part and a support part are formed is formed. A material (gel) was obtained. Transparency, bending and restoration were evaluated in a state where the obtained base material was sufficiently hydrated.
In the bending, it was evaluated whether the optical part could be further folded in a state where the support part was bent using an insulator and placed on the optical part. Furthermore, the optical part folded in the state in which the support part was placed was released from the insulator, and it was evaluated whether both the optical part and the support part could be restored to the original state without damage. If it was possible to bend and restore without breakage, it was rated as ○. In addition, the refractive index was measured and evaluated by a tensile test. The refractive index was measured using a refractometer (RA-600 manufactured by Kyoto Electronics Industry Co., Ltd.) at 23 ° C. and D line. The tensile test was performed at 23 ° C. using a desktop material testing machine (STA-1150, manufactured by Orientec Corp.). The results are shown in Table 1.
<実施例2>
モノマーとして、N,N´-ジメチルアクリルアミドを0.75M、ラウリルアクリレート(LA)を0.05M、ステアリルアクリレートを0.2M、架橋剤としてN,N´-メチレンビスアクリルアミドを0.05Mol%、重合開始剤としてベンゾフェノンを0.1Mol%の割合で秤量し、混合した。この混合液を不活性ガス下(窒素ガス)のもとで15分間撹拌した。実施例1と同様に所定の型枠に混合液を流し込み、紫外線ランプを24時間照射させ、光学部と支持部とが形成された1ピースプレート型眼内レンズを模した形状の基材(ゲル)を得た。得られた基材に対して実施例1と同じ評価を行った。その結果を表1に示す。
<実施例3>
モノマーとして、N,N´-ジメチルアクリルアミドを0.75M、ラウリルアクリレートを0.1M、ステアリルアクリレートを0.15M、架橋剤としてN,N´-メチレンビスアクリルアミドを0.05Mol%、重合開始剤としてベンゾフェノンを0.1Mol%の割合で秤量し、混合した。この混合液を不活性ガス下(窒素ガス)のもとで15分間撹拌した。実施例1と同様に所定の型枠に混合液を流し込み、紫外線ランプを24時間照射させ、光学部と支持部とが形成された1ピースプレート型眼内レンズを模した形状の基材(ゲル)を得た。得られた基材に対して実施例1と同じ評価を行った。その結果を表1に示す。
<Example 2>
0.75M N, N'-dimethylacrylamide as monomer, 0.05M lauryl acrylate (LA), 0.2M stearyl acrylate, 0.05Mol% N, N'-methylenebisacrylamide as a cross-linking agent, polymerized Benzophenone as an initiator was weighed at a ratio of 0.1 mol% and mixed. The mixture was stirred for 15 minutes under inert gas (nitrogen gas). In the same manner as in Example 1, the mixture was poured into a predetermined mold, irradiated with an ultraviolet lamp for 24 hours, and a base material (gel) imitating a one-piece plate type intraocular lens in which an optical part and a support part were formed ) The same evaluation as Example 1 was performed with respect to the obtained base material. The results are shown in Table 1.
<Example 3>
As monomers, N, N'-dimethylacrylamide is 0.75M, lauryl acrylate is 0.1M, stearyl acrylate is 0.15M, N, N'-methylenebisacrylamide is used as a crosslinking agent, and 0.05Mol% as a polymerization initiator. Benzophenone was weighed at a ratio of 0.1 mol% and mixed. The mixture was stirred for 15 minutes under inert gas (nitrogen gas). In the same manner as in Example 1, the mixture was poured into a predetermined mold, irradiated with an ultraviolet lamp for 24 hours, and a base material (gel) imitating a one-piece plate type intraocular lens in which an optical part and a support part were formed ) The same evaluation as Example 1 was performed with respect to the obtained base material. The results are shown in Table 1.
<比較例1>
モノマーとして、N,N´-ジメチルアクリルアミドを1M、架橋剤としてN,N´-メチレンビスアクリルアミドを0.05Mol%、重合開始剤としてα-ケトグルタル酸を0.1Mol%の割合で秤量し、混合した。この混合液を不活性ガス下(窒素ガス)のもとで15分間撹拌した。実施例1と同様に所定の型枠に混合液を流し込み、紫外線ランプを24時間照射させ、光学部と支持部とが形成された1ピースプレート型眼内レンズを模した形状の基材(ゲル)を得た。得られた基材に対して実施例1と同じ評価を行った。その結果を表1に示す。
<Comparative Example 1>
Weigh and mix 1M N, N'-dimethylacrylamide as monomer, 0.05Mol% N, N'-methylenebisacrylamide as crosslinking agent, and 0.1Mol% α-ketoglutaric acid as polymerization initiator. did. The mixture was stirred for 15 minutes under inert gas (nitrogen gas). In the same manner as in Example 1, the mixture was poured into a predetermined mold, irradiated with an ultraviolet lamp for 24 hours, and a base material (gel) imitating a one-piece plate type intraocular lens in which an optical part and a support part were formed ) The same evaluation as Example 1 was performed with respect to the obtained base material. The results are shown in Table 1.
結果:実施例1乃至実施例3にて作成したゲルは何れも透明性が良好であり、折り曲げ・復元も破損なく良好であった。本実施形態で得られたゲルの屈折率は、水の屈折率(1.33程度)よりも高く、生体内にてレンズとして用いることができる条件であることが確認された。 Results: All the gels prepared in Examples 1 to 3 had good transparency, and the bending and restoration were good without breakage. The refractive index of the gel obtained in this embodiment is higher than the refractive index of water (about 1.33), and it was confirmed that the conditions were such that it could be used as a lens in vivo.
1 眼内レンズ
2 光学部
3 支持部
1 Intraocular lens 2 Optical part 3 Support part
Claims (5)
The eye according to claim 4, wherein the acrylic hydrophobic monomer used as a composition of the optical part and the support part is an acrylate containing an alkyl group having 12 to 18 carbon atoms or a derivative thereof in a side chain. Inner lens.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012260647A JP2014104239A (en) | 2012-11-29 | 2012-11-29 | Intraocular lens |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012260647A JP2014104239A (en) | 2012-11-29 | 2012-11-29 | Intraocular lens |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014104239A true JP2014104239A (en) | 2014-06-09 |
JP2014104239A5 JP2014104239A5 (en) | 2016-01-21 |
Family
ID=51026220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012260647A Pending JP2014104239A (en) | 2012-11-29 | 2012-11-29 | Intraocular lens |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2014104239A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020250677A1 (en) * | 2019-06-14 | 2020-12-17 | 株式会社 資生堂 | Resin having shape-memory property, article for external use on skin, and method for producing article for external use on skin |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5013059A (en) * | 1973-04-04 | 1975-02-10 | ||
JP2002253585A (en) * | 2001-02-28 | 2002-09-10 | Canon Star Kk | Intraocular implant |
JP2013057062A (en) * | 2011-08-18 | 2013-03-28 | Eiko Furukawa | Transparent shape-memory gel, lens using the gel, and method of adjusting focal point of lens |
-
2012
- 2012-11-29 JP JP2012260647A patent/JP2014104239A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5013059A (en) * | 1973-04-04 | 1975-02-10 | ||
JP2002253585A (en) * | 2001-02-28 | 2002-09-10 | Canon Star Kk | Intraocular implant |
JP2013057062A (en) * | 2011-08-18 | 2013-03-28 | Eiko Furukawa | Transparent shape-memory gel, lens using the gel, and method of adjusting focal point of lens |
Non-Patent Citations (1)
Title |
---|
JPN6016029278; YOKOO, Tomohiro et al.: 'Smart Lenses Developed with High-Strength and Shape Memory Gels' e-Journal of Surface Science and Nanotechnology Vol. 10, 20120616, p.243-247 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020250677A1 (en) * | 2019-06-14 | 2020-12-17 | 株式会社 資生堂 | Resin having shape-memory property, article for external use on skin, and method for producing article for external use on skin |
CN113993917A (en) * | 2019-06-14 | 2022-01-28 | 株式会社资生堂 | Shape memory resin, external skin appliance, and method for producing external skin appliance |
US20220242986A1 (en) * | 2019-06-14 | 2022-08-04 | Shiseido Company, Ltd. | Shape memory resin, article for external use on skin, and method for producing article for external use on skin |
CN113993917B (en) * | 2019-06-14 | 2024-01-16 | 株式会社资生堂 | Shape memory resin, external skin appliance and method for producing external skin appliance |
JP7558937B2 (en) | 2019-06-14 | 2024-10-01 | 株式会社 資生堂 | Shape-memory resin, skin beauty product, method for manufacturing skin care equipment, and method for manufacturing skin beauty product |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3342031B2 (en) | Intraocular lens and its manufacturing method | |
JP3725431B2 (en) | Water plasticized high refractive index polymer for the eye | |
KR100438477B1 (en) | Intraocular lenses and process for producing molded-in type intraocular lenses | |
AU675468B2 (en) | Ophthalmic lens polymer incorporating acyclic monomer | |
TWI664471B (en) | Silicone elastomer-hydrogel hybrid contact lenses and manufacturing methods thereof | |
KR101982897B1 (en) | Hydrophobic intraocular lens | |
JP5096793B2 (en) | Polymer composition and ophthalmic lens body | |
JP5591468B2 (en) | Device materials for ophthalmology and otolaryngology | |
US20020049290A1 (en) | High refractive index hydrogel compositions for ophthalmic implants | |
CN1582292A (en) | High refractive index polymeric siloxysilane compositions | |
CN1662568A (en) | Low water content high refractive index, flexible, polymeric compositions | |
CN1681862A (en) | Elastomeric, expandable hydrogel compositions | |
KR101695505B1 (en) | Intraocular lens | |
CN1063551C (en) | Polymeric ophthalmic lens with crosslinker containing saccharide residue | |
CN101896514B (en) | Biomedical devices | |
AU712171B2 (en) | High refractive index hydrogels prepared from polymers and copolymers of N-benzyl-N-methylacrylamide | |
CN105037629A (en) | Silicone hydrogel with good resilience and preparation method and application method therefor | |
WO2010077709A2 (en) | Biomedical devices | |
JP2014104239A (en) | Intraocular lens | |
WO2019228224A1 (en) | Polymer material and intraocular lens | |
JP2006030851A (en) | Contact lens material | |
JPH0215233A (en) | Highly hydrous lens material for eye | |
JP2013502302A (en) | Ophthalmic and ENT equipment materials | |
US20210253753A1 (en) | Gel material | |
US20250073018A1 (en) | Ophthalmic devices having a high refractive index |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151127 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20151127 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160802 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20170307 |